Free Trial

Bridgeway Capital Management LLC Grows Stock Position in AdaptHealth Corp. (NASDAQ:AHCO)

AdaptHealth logo with Medical background

Bridgeway Capital Management LLC boosted its stake in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 27.2% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 1,324,043 shares of the company's stock after buying an additional 283,143 shares during the period. Bridgeway Capital Management LLC owned approximately 0.98% of AdaptHealth worth $12,605,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of AHCO. Assetmark Inc. purchased a new stake in shares of AdaptHealth in the fourth quarter worth approximately $28,000. Blue Trust Inc. raised its holdings in shares of AdaptHealth by 24.1% in the 4th quarter. Blue Trust Inc. now owns 5,746 shares of the company's stock valued at $55,000 after purchasing an additional 1,115 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its position in shares of AdaptHealth by 15.4% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company's stock worth $121,000 after purchasing an additional 1,690 shares during the period. Guggenheim Capital LLC increased its holdings in AdaptHealth by 10.1% during the fourth quarter. Guggenheim Capital LLC now owns 16,613 shares of the company's stock valued at $158,000 after buying an additional 1,525 shares during the period. Finally, KLP Kapitalforvaltning AS bought a new position in AdaptHealth in the fourth quarter worth approximately $169,000. 82.67% of the stock is currently owned by institutional investors.

AdaptHealth Stock Performance

NASDAQ AHCO traded up $0.15 on Thursday, hitting $8.38. 2,039,767 shares of the company's stock traded hands, compared to its average volume of 1,277,777. The firm has a market capitalization of $1.13 billion, a PE ratio of -5.08, a P/E/G ratio of 1.08 and a beta of 1.64. AdaptHealth Corp. has a 1-year low of $7.11 and a 1-year high of $11.90. The firm's 50-day moving average price is $9.32 and its two-hundred day moving average price is $9.76. The company has a current ratio of 1.24, a quick ratio of 1.00 and a debt-to-equity ratio of 1.34.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the company. Canaccord Genuity Group lifted their price target on AdaptHealth from $13.00 to $14.00 and gave the company a "buy" rating in a report on Wednesday, February 26th. Royal Bank of Canada reduced their target price on shares of AdaptHealth from $14.00 to $13.00 and set an "outperform" rating for the company in a report on Thursday. UBS Group decreased their price target on shares of AdaptHealth from $12.00 to $11.00 and set a "buy" rating for the company in a research report on Thursday, February 13th. Robert W. Baird boosted their price objective on shares of AdaptHealth from $14.00 to $16.00 and gave the stock an "outperform" rating in a research note on Thursday, February 27th. Finally, Truist Financial raised their target price on shares of AdaptHealth from $12.00 to $14.00 and gave the company a "buy" rating in a research note on Wednesday, February 26th. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, AdaptHealth has a consensus rating of "Buy" and a consensus price target of $13.60.

Read Our Latest Report on AdaptHealth

AdaptHealth Profile

(Free Report)

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.

Featured Stories

Institutional Ownership by Quarter for AdaptHealth (NASDAQ:AHCO)

Should You Invest $1,000 in AdaptHealth Right Now?

Before you consider AdaptHealth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AdaptHealth wasn't on the list.

While AdaptHealth currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss
Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines